Search Results for: CMRX
February 23, 2016: Here are four stocks trading with heavy volume among 46 equities making new 52-week lows today. PTC Therapeutics Inc. (NASDAQ: PTCT) dropped about 59% on Tuesday to post a new...
Published:
Last Updated:
Chimerix had a bad start to the week as it tumbled in early trading on Monday, following some late stage clinical trial results.
Published:
Last Updated:
December 28, 2015: Here are four stocks trading with heavy volume among 34 equities making new 52-week lows today. Chimerix Inc. (NASDAQ: CMRX) dropped about 81% on Monday to post a new 52-week low...
Published:
Last Updated:
Chimerix reported mixed fourth-quarter financial results before the markets opened on Monday.
Published:
Last Updated:
The sad news that Ebola patient Thomas Eric Duncan has died in a Dallas hospital now raises fears that Ebola drugs might not be a cure-all for patients.
Published:
Tuesday's top analyst calls were in shares of Albermarle, Atara Biotherapeutics, Chimerix, IHS, NetApp, Pure Storage and more.
Published:
Last Updated:
Tekmira Pharmaceuticals downgrade also drags down Sarepta Therapeutics and BioCryst Pharmaceuticals.
Published:
Chimerix absolutely led the bears in Monday’s trading session on less-than-favorable results from a late-stage trial.
Published:
Last Updated:
Investors and traders alike always seem to be on the lookout for new speculative investment ideas that can generate massive long-term or short-term gains. While investors get to see many Buy ratings...
Published:
Last Updated:
Chimerix has announced that its lead drug candidate has been provided for potential use in patients with Ebola virus disease.
Published:
Tuesday's top analyst upgrades, downgrades and initiations include Barclays, Caterpillar, EMC, JD.com, LinkedIn and Stratasys.
Published:
Recently we have seen a surge in Ebola-related stocks across the board, but Friday trading brought a mixed view for this group.
Published:
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, February 13, 2014. They include Angie's List, Itron, NVIDIA, Regeneron and Sempra...
Published:
With the summer doldrums over, the stock market is starting to return to normal. We also saw some very large insider selling in a top European pharmaceutical stock.
Published:
Investors fan the flames of Ebola fears in the market, enabling these biotech companies to profit from these fears.
Published: